|
ATP6V1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.073800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.069600E-02 |
| Normal-vs-Stage2 |
8.115600E-02 |
| Normal-vs-Stage3 |
3.730600E-01 |
| Normal-vs-Stage4 |
2.253200E-01 |
| Stage1-vs-Stage2 |
5.887200E-01 |
| Stage1-vs-Stage3 |
2.899200E-01 |
| Stage1-vs-Stage4 |
8.110000E-01 |
| Stage2-vs-Stage3 |
2.315000E-01 |
| Stage2-vs-Stage4 |
5.551000E-01 |
| Stage3-vs-Stage4 |
6.038000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.258040E-01 |
| Normal-vs-AfricanAmerican |
9.778300E-03 |
| Normal-vs-Asian |
2.551400E-01 |
| Caucasian-vs-AfricanAmerican |
1.927630E-02 |
| Caucasian-vs-Asian |
8.155800E-01 |
| AfricanAmerican-vs-Asian |
1.015210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.579600E-01 |
| Normal-vs-Female |
2.064100E-02 |
| Male-vs-Female |
1.544770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.585500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.376030E-01 |
| Normal-vs-Age(61-80Yrs) |
9.174200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.494600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.315000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.183800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.249780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.420600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.940770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.517620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.978200E-01 |
| Classical-VS-Follicular |
2.988800E-01 |
| Classical-VS-Other |
1.353960E-01 |
| Classical-VS-Normal |
1.400050E-02 |
| Tall-VS-Follicular |
6.549000E-01 |
| Tall-VS-Other |
1.172780E-01 |
| Tall-VS-Normal |
1.498960E-01 |
| Follicular-VS-Other |
3.060800E-01 |
| Follicular-VS-Normal |
2.866200E-01 |
| Other-VS-Normal |
3.904600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.167400E-01 |
| Normal-vs-N1 |
6.927000E-01 |
| N0-vs-N1 |
6.129200E-01 |
|
|
